Deep Dive In Vitiligo

Yan Valle

Explore the powerful story of vitiligo—a ‘white armor’ that challenges, empowers, and inspires resilience. Join us weekly as we delve into the science, medicine, philosophy, and personal experiences behind this intricate skin condition. Hosted by Yan Valle, CEO of the VR Foundation and author of Amazon’s bestselling book on vitiligo, this podcast breaks down cutting-edge research and celebrates stories of strength. With our engaging AI-driven anchors, we make even complex ideas both accessible and captivating. Let’s dive in together and reimagine what it means to embrace, thrive, and shine with vitiligo!

  1. Nov 14

    Vitiligo, Veterans, and the 10% Rule (Ep. 83)

    Ten percent. That's how the U.S. Department of Veterans Affairs rates vitiligo when it affects exposed skin. Zero percent when it doesn't. Simple enough on paper. But what does that actually mean for veterans living with vitiligo, and how do you navigate the VA system to get the benefits you may be entitled to? In this episode of Deep Dive in Vitiligo, we take a practical look at VA disability benefits for vitiligo. We explain how the rating system works, walk through the main steps of filing a claim, and outline the medical records, supporting evidence, and paperwork that can help make your case. Along the way, we explore why the impact of vitiligo on military careers, mental health, and everyday life isn't always reflected in a disability percentage. In this episode, we discuss: The 10% rule: How the VA rates vitiligo and what qualifies for compensation. Filing a claim: The main steps, eligibility requirements, and what to expect along the way. Getting your paperwork right: Medical records, service connection evidence, photographs, and other supporting documentation. Beyond the rating: What to consider when vitiligo affects mental health, work, or quality of life. Whether you're preparing your first VA claim, trying to understand an existing rating, or simply wondering what support is available, this episode offers a clear starting point without drowning you in government jargon. Because ten percent may be the number on the paperwork. It doesn't have to be the whole story.

  2. Nov 11

    Clinical Trials in Vitiligo: The People Behind Tomorrow's Treatments (Ep. 82)

    Take a look inside your bathroom cabinet. Every prescription cream, every medicine you rely on, has a story behind it. Somewhere along the way, someone volunteered for a clinical trial, accepted a little uncertainty, and helped make that treatment possible. Most of us will never know their names. But we all benefit from their decisions. For someone living with vitiligo, joining a clinical trial may offer access to an experimental treatment, expert medical care, and a chance to help develop better therapies for everyone. But there's a practical side to that decision: time off work, missed school, long journeys to the clinic, extra tests, and perhaps giving up a cream that's finally helping. All without any guarantee of improvement. In this episode of Deep Dive in Vitiligo, we explore the opportunities, uncertainties, and everyday realities of clinical research, drawing on VRF resources, conversations at the recent Vitiligo Leadership Forum in Goa, India, and lessons from patient recruitment. In this episode, we discuss: Why clinical trials matter: How today's volunteers make tomorrow's treatments possible. The hidden costs of participation: Travel, time, family responsibilities, and the logistics of fitting research into real life. Placebos and uncertainty: Why existing treatments sometimes need to be paused and why results can never be guaranteed. Parents and children: Why deciding for your child can be harder than deciding for yourself. What makes people say yes or no: And how VRF's new multilingual survey aims to understand those decisions. Clinical trials need volunteers, but volunteers have lives beyond the clinic. Our goal isn't to persuade everyone to enroll. It's to help people make informed choices and researchers design studies that more patients can realistically join. After all, someone helped make the treatments in your bathroom cabinet possible. Perhaps one day, someone else will be grateful you did the same.

  3. Sep 7

    Dos ensayos de ruxolitinib en niños con vitiligo. Misma crema. Distinto mapa (Ep. 76)

    Durante años, la crema aprobada se detenía a los 12. Los más pequeños se quedaban con el menú de siempre: corticoides, tacrolimus, luz si había hueco, y mucha espera. Eso empieza a cambiar. Hay dos ensayos de fase 3 con crema de ruxolitinib — Opzelura, si ya conoces el tubo — en niños con la forma más común de vitíligo. Protocolos de verdad. Centros de verdad. No un rumor de un grupo de padres. El matiz: no son el mismo estudio. Si los mezclas, una familia reserva viaje al continente equivocado. En este episodio de *Deep Dive in Vitiligo* ponemos los dos ensayos uno al lado del otro. Vas a escuchar: El ensayo norteamericano TRuE-ViP (NCT06548360): de 2 a 11 años, Estados Unidos y Canadá, unos 180 niños El ensayo internacional (NCT06804811, Incyte INCB18424-309): a partir de los 6 años, Argentina más 13 países europeos, unos 250 niños, sin centros en EE. UU. ni Canadá Lo que comparten: solo vitíligo no segmentario, un techo del 10% de superficie corporal, crema vehículo las primeras 24 semanas, la cara como medida principal en la semana 24, y la obligación de pausar otros tratamientos para el vitíligo, incluida la fototerapia Por qué un niño de 8 años puede cumplir la edad en los dos y no encajar en ninguno por código postal No suspendas un tratamiento que ya funciona porque en la misma semana aparecieron dos páginas de ensayo. Pregunta en el centro qué habría que pausar. Después llama al dermatólogo habitual del niño. Sí es una respuesta razonable. No también. La pregunta útil es qué protocolo — si es que alguno — encaja con este niño, en este país, con esta agenda.

Ratings & Reviews

3
out of 5
2 Ratings

About

Explore the powerful story of vitiligo—a ‘white armor’ that challenges, empowers, and inspires resilience. Join us weekly as we delve into the science, medicine, philosophy, and personal experiences behind this intricate skin condition. Hosted by Yan Valle, CEO of the VR Foundation and author of Amazon’s bestselling book on vitiligo, this podcast breaks down cutting-edge research and celebrates stories of strength. With our engaging AI-driven anchors, we make even complex ideas both accessible and captivating. Let’s dive in together and reimagine what it means to embrace, thrive, and shine with vitiligo!

You Might Also Like